TO: |
Regulatory Information
Service
PR Newswire |
RE: |
PARAGRAPH 3.1.4 OF THE
DISCLOSURE AND TRANSPARENCY RULES |
The notifications listed below were all received under Paragraph
3.1.2 of the Disclosure and Transparency Rules.
Diageo plc (the "Company") announces that:
1. It received notification on 10 June
2015 of the following allocations of ordinary shares of 28
101/108 pence each in the Company (“Ordinary
Shares”) under the Diageo Share Incentive Plan (the "Plan"),
namely:
(i) the following director of the Company was allocated Ordinary
Shares on 10 June 2015 under the Plan, by Diageo Share
Ownership Trustees Limited (the "Trustee"):
Name of Director |
Number of Ordinary
Shares |
D Mahlan |
9 |
(ii) the following Persons Discharging Managerial
Responsibilities (“PDMR”) were allocated Ordinary Shares on
20 June 2015 under the Plan, by the
Trustee:
Name of PDMR |
Number of Ordinary Shares |
N Blazquez |
9 |
D Cutter |
10 |
S Moriarty |
9 |
L Wood |
11 |
The number of Ordinary Shares allocated comprises those
purchased on behalf of the employee using an amount which the
employee has chosen to have deducted from salary ("Sharepurchase")
and those awarded to the employee by the Company ("Sharematch") on
the basis of one Sharematch Ordinary Share for every two
Sharepurchase Ordinary Shares.
The Sharepurchase Ordinary Shares were purchased and the
Sharematch Ordinary Shares were awarded at a price per share of
£18.75.
The Ordinary Shares are held by the Trustee and in the name of
the Trustee. Sharepurchase Ordinary Shares can normally be sold at
any time. Sharematch Ordinary Shares cannot normally be disposed of
for a period of three years after the award date.
2. It received notification on 10 June
2015 that Dr FB Humer, a director of the Company, had
purchased 441 Ordinary Shares on 10 June
2015 under an arrangement with the Company, whereby he has
agreed to use an amount of £8,000 each month, net of tax, from his
director's fees to purchase Ordinary Shares. Dr Humer has agreed to
retain the Ordinary Shares while he remains a director of the
Company.
The Ordinary Shares were purchased at a price per share of
£18.75.
The Ordinary Shares referred to in items 1 and 2 above were
purchased on the London Stock Exchange.
As a result of the above transactions, interests of directors
and PDMRs in the Company's Ordinary Shares and American Depository
Shares (“ADS”)* (excluding options, awards under the Company's
LTIPs and interests as potential beneficiaries of the Company’s
Employee Benefit Trusts) are as follows:
Name of Director |
Number of Ordinary Shares |
Dr FB Humer |
60,097 |
D Mahlan |
280,571 (of which 137,626 are held
as ADS)* |
Name of PDMR |
Number of Ordinary Shares |
N Blazquez |
79,422 |
D Cutter |
11,911** |
S Moriarty |
42,358 |
L Wood |
5,992 |
|
|
J Fahey
Senior Company Secretarial Assistant
10 June 2015
* 1 ADS is the equivalent of 4 Ordinary Shares.
** The change from previously announced figure is due to a
reclassification of 1,077 Ordinary Shares, that no longer form part
of the number of Ordinary Shares held by Mr Cutter.